Canadian-Special-Risks near De Salaberry MB (314 Result(s))

Saving Lives Through Early Disease DiagnosisMiraculins is an emerging biotechnology company committed to extending life, reducing suffering and lowering healthcare costs. Through our leadership in the development and commercialization of diagnostic tests, we strive to improve the overall diagnosis and treatment of patients by enhancing the information available to physicians.The Miraculins AdvantageProducts & ProgramsMiraculins is dedicated to the development and commercialization of diagnostic tests and risk assessment technologies for diseases and conditions that are lacking highly sensitive and specific tests.

David Riddell, President of Canadian Claims Services Inc is pleased to announce the additions of Larissa Grace, Kerry Reid, Kenna Freeman, Jameson Ade, and PJ Gill congratulate these new members of our team! June 13, 2013CCS New Staff!David Riddell, President of Canadian Claims Services Inc is pleased to announce the additions of Dawn Fuchs, and Mark Mikkelson. Please congratulate these new members of our team!We listen and effectively respond to your needs and those of your clients. Our team of experienced experts has the latest technology working for them to ensure cost and risk is always at a minimum.Our edge is our innovative Online Claims Management System which provides both clients and CCS staff with the most powerful solution in the industry. The Assignment Submission Form will open in a new window after you click ''Submit Assignment''. Fill in as much detail as possible and click ''Save Assignment'' at the bottom of the submission page. Please contact us if you have any questions or require assistance.See the Difference Today

Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.

From ping pong to pool to video and redemption games, we've got it all for you to play. Your destination for Canadian inspired food, exciting games, & endless entertainment.

Find a Tax Professional at H&R Block, the brand clients have trusted for over 50 years for income tax preparation. With over 1200 locations nationwide expertise is just around the corner.